Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,612 | -3,359 | -1,284 | -2,115 | -1,114 |
| Depreciation Amortization | 84 | 51 | 22 | 76 | 55 |
| Other Working Capital | 1,585 | 932 | 384 | 100 | 102 |
| Other Operating Activity | 33 | 0 | 0 | 480 | 5 |
| Operating Cash Flow | $-4,910 | $-2,375 | $-879 | $-1,459 | $-951 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -112 | -89 | -42 | -73 | -59 |
| Investing Cash Flow | $-112 | $-89 | $-42 | $-73 | $-59 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 842 | 924 |
| Common Stock Issued | 129 | 30 | N/A | 100 | N/A |
| Other Financing Activity | 7,870 | 7,870 | 7,870 | 1,005 | 0 |
| Financing Cash Flow | $7,999 | $7,900 | $7,870 | $1,947 | $924 |
| Beginning Cash Position | 504 | 504 | 504 | 89 | 89 |
| End Cash Position | 3,480 | 5,940 | 7,453 | 504 | 3 |
| Net Cash Flow | $2,977 | $5,436 | $6,949 | $415 | $-86 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,910 | -2,375 | -879 | -1,459 | -951 |
| Capital Expenditure | -112 | -89 | -42 | -73 | -59 |
| Free Cash Flow | -5,022 | -2,464 | -921 | -1,532 | -1,010 |